首頁 » 【新冠疫苗】科興臨牀數據60歲以上抗體比率逾90% 牛津大學測試混合接種BioNTech/輝瑞、牛津/阿斯利康疫苗效用 » the-Society-of-Hospital-Pharmacists-of-Hong-Kong_20210125_01 the-Society-of-Hospital-Pharmacists-of-Hong-Kong_20210125_01